Inogen Backs 2015 Guidance - Quick Facts

(RTTNews) - Inogen, Inc. (INGN), a medical technology company, Monday confirmed its full year 2015 guidance of net income of $8.5 to $10 million and revenue of $150 to $153 million.

The firm expects adjusted EBITDA for the full year 2016 to be in the range of $35 to $37 million, representing an approximate increase of 14.8 to 21.3 percent over the 2015 guidance mid-point of $30.5 million.

The company also expects net income of $11 to $13 million, representing 18.9 to 40.5 percent growth over the 2015 guidance mid-point of $9.25 million.

The company expects net positive cash flow for 2016 with no additional equity capital required to meet its current plan.

Inogen confirmed total revenue guidance for the full year 2016 of $177 to $183 million, representing 16.8 to 20.8 percent growth over the 2015 guidance mid-point of $151.5 million.